DDX3X and colorectal carcinoma: Downregulation of DDX3X enhanced proliferation, migration and invasion of CRC cells in vitro and enhanced tumor metastasis in vivo by inhibiting E-cadherin and activating β-catenin signaling via suppressing the MAPK pathway (81, 82) (Figure 8).